In Week of Mar 28, 2026, Shri Ahimsa Naturals Ltd (Chemicals - Organic) is outperforming Nifty 500 with +11.0% relative strength. Fundamentals: Average.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on Q2 FY26 (September 2025) earnings • Updated Mar 21, 2026
What: New Ankleshwar plant commissioning with 22%+ OPM contribution
Impact: +₹45 Cr revenue
“MD & CEO stated: 'The new specialty chemicals plant is now operational and we expect it to contribute ₹45 cr in Q4 alone with margins significantly higher than our current portfolio'”
What: REACH and FDA certifications enabling premium export business
Impact: +₹35 Cr revenue
“CFO statement: 'With our recent REACH and FDA certifications, we're positioned to capture $15 million in new export business annually with premium pricing'”
What: Strategic shift from commodity to specialty products improving margins
Impact: +₹120 Cr revenue
“MD & CEO: 'Our specialty products now constitute 45% of revenue, up from 32% last year, and this trend will continue as we focus on high-value segments with better pricing power'”
Earnings deceleration risks from management commentary
Trigger: Sustained crude >$90/bbl
Impact: -200 bps margin impact
Management view: CFO: 'While we have hedged 60% of our feedstock requirements for next 6 months, prolonged high crude prices could pressure margins despite our partial pass-through mechanism'
Monitor: Crude oil prices, feedstock cost trends
Trigger: New EU regulations
Impact: -300 bps margin impact
Management view: MD & CEO: 'We're closely monitoring potential regulatory changes in Europe which could require additional investments in our production processes'
Monitor: EU chemical regulation updates
Key quotes from recent conference calls
“The new specialty chemicals plant is now operational and we expect it to contribute ₹45 cr in Q4 alone with margins significantly higher than our current portfolio — Mr. Rajesh Ahimsa”
“With our recent REACH and FDA certifications, we're positioned to capture $15 million in new export business annually with premium pricing — CFO”
“Our specialty products now constitute 45% of revenue, up from 32% last year, and this trend will continue as we focus on high-value segments with better pricing power — MD & CEO”
“We remain confident of achieving 25-30% revenue growth and 14-15% OPM for full year FY26 — MD & CEO”
Forward-looking targets from management for FY26
Revenue Growth Target
25%
Implied PAT Growth
27.5%
OPM Guidance
14.5%
Capex Plan
₹85 Cr
Key Milestones
• Ankleshwar plant at 95% utilization by Q1 FY27
• Export revenue growth to 45% of total
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +49% | -4% | Insufficient Data |
| PAT (Net Profit) | +50% | -24% | Insufficient Data |
| OPM | 30.0% | -400 bps | Insufficient Data |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Mar 21, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Shri Ahimsa Naturals Ltd's latest quarterly results (Sep 2025) show
Shri Ahimsa Naturals Ltd's profit is growing with an insufficient_data trend.
Shri Ahimsa Naturals Ltd's revenue growth trend is insufficient_data.
Shri Ahimsa Naturals Ltd's operating margin is insufficient_data.
Shri Ahimsa Naturals Ltd's long-term compounding rates
Shri Ahimsa Naturals Ltd's earnings growth is insufficient_data with insufficient_data on a sequential basis.
Shri Ahimsa Naturals Ltd appears fairly valued based on our fair value analysis.
Shri Ahimsa Naturals Ltd's current PE ratio is 21.5x.
Shri Ahimsa Naturals Ltd's current PE is 21.5x.
Shri Ahimsa Naturals Ltd's price-to-book ratio is 3.4x.
Shri Ahimsa Naturals Ltd is rated Average with a fundamental score of 43.45/100. This score is calculated from objective financial metrics
Shri Ahimsa Naturals Ltd has a debt-to-equity ratio of N/A.
Shri Ahimsa Naturals Ltd's return ratios over recent years
Shri Ahimsa Naturals Ltd's operating cash flow is positive (FY2025).
Shri Ahimsa Naturals Ltd currently does not pay a significant dividend (yield 0.00%).
Shri Ahimsa Naturals Ltd's shareholding pattern (Sep 2025)
Shri Ahimsa Naturals Ltd's promoter holding has remained stable recently.
Shri Ahimsa Naturals Ltd has been outperforming Nifty 500 for 2 consecutive weeks, indicating early-stage outperformance.
Shri Ahimsa Naturals Ltd is an established outperformer with 2 weeks of consecutive Nifty 500 outperformance.
Shri Ahimsa Naturals Ltd has 3 key growth catalysts identified from recent earnings analysis
Shri Ahimsa Naturals Ltd has 2 key risks worth monitoring
In Q2 FY26 (September 2025), Shri Ahimsa Naturals Ltd's management highlighted
Shri Ahimsa Naturals Ltd's management has provided the following forward guidance for FY26
Based on quantitative research signals, here is why Shri Ahimsa Naturals Ltd may be worth studying
Shri Ahimsa Naturals Ltd investment thesis summary:
Shri Ahimsa Naturals Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
